{
  "meta": {
    "title": "Obstetrics_Gynecology_Mini_Test_8",
    "url": "https://brainandscalpel.vercel.app/obstetrics-gynecology-mini-test-8-c1ccf861.html",
    "scrapedAt": "2025-11-30T07:32:56.017Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous epithelium at squamocolumnar junction</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Columnar epithelium at squamocolumnar junction</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous epithelium at transformational zone</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Columnar epithelium at transformational zone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">At which of the following regions does the carcinoma cervix usually develop ?</span></p>",
      "unique_key": "Q237676",
      "question_audio": null,
      "question_video": null,
      "map_id": 237676,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Squamocolumnar junction is the meeting point of the columnar epithelium of endocervix with the squamous epithelium of the ectocervix and is the most common site of Ca cervix.</strong></p><ul><li>It is a dynamic junction</li><li>It moves up and down the in relation to different phases of life</li><li>Metaplasia extends from original SCJ to the new SCJ. this area is known as transformational zone</li><li>Prolonged effect of carcinogen can cause alteration in the immature squamous epithelium of the transformational zone</li></ul><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/1E.jpg\"><p>Risk factors for carcinoma cervix</p><ul><li>HPV infection (6, 11, 16, 18)</li><li>HIV, immunosuppression</li><li>HSV</li><li>Chlamydia</li><li>Multiple sexual partners</li><li>Increasing age</li><li>Smoking</li><li>Low socioeconomic status</li></ul><p><strong>Reference:</strong> D.C. dutta textbook of gynecology. Chapter 23, premalignant lesion, page number:262</p>",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">5 % acetic acid is used</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Has high sensitivity</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetowhite areas reflect premalignant lesions</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">It has low false positive rate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following is a test to screen for a genital malignancy. What is not true about the test? <br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/2Q.jpg\"></span></p>",
      "unique_key": "Q237677",
      "question_audio": null,
      "question_video": null,
      "map_id": 237677,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The image shows visual inspection with acetic acid(VIA) used for screening for carcinoma cervix. Following are some of the important points about VIA:</p><ul><li><strong>Apply 5 % acetic acid to cervix (Option A)</strong></li><li>Acetic acid causes protein denaturation and hence acetowhite areas are formed</li><li><strong>As premalignant lesions have more protein, they stain acetowhite (Option C)</strong></li><li>Positive VIA test is indicated by well defined acetowhite areas</li><li>Positive patients need to be followed up for colposcopy</li><li><strong>High sensitivity with high false positive values (Option B)</strong></li><li>Low specificity</li></ul><p><strong>Reference:</strong> textbook of gynecology, J.B. Sharma 2/edition. Section 6, benign and premalignant lesions. Page number:599</p>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Clamping the round ligament</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Clamping the uterine artery</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Clamping the uterosacral ligament</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Clamping the infundibulopelvic ligament</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35 year old female is diagnosed with carcinoma cervix. There is no metastasis or invasion. The depth of lesion is 4 mm and the horizontal spread is 5 mm. Which of the following is not a part of the operation conducted for the same ?</span></p>",
      "unique_key": "Q237678",
      "question_audio": null,
      "question_video": null,
      "map_id": 237678,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The diagnosis of the patient is carcinoma cervix (stage 1A2) and the surgical management involves hysterectomy. Since the patient is pre menopausal, ovary needs to be preserved. Hence the infundibulopelvic ligaments are not clamped in the process.</p><p>Following is the FIGO staging of CA cervix and its management:</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/3E.jpg\"><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/3E1.jpg\"><p>The major steps of abdominal hysterectomy are</p><ul><li>Abdomen opened</li><li><strong>The round ligaments are clamped, cut and ligated (Option A)</strong></li><li>Window is created in the avascular window of the round ligament</li><li><strong>If ovaries are to be removed, clamp is applied to infundibulopelvic ligament reaching upto the window</strong></li><li>If ovaries are to preserved then the clamp is applies to the cornual structures and tips passed through the window</li><li>Uterovesical fold is separated</li><li><strong>Uterine artery is skeletonized, clamped, cut and ligated(Option B)</strong></li><li><strong>Uterosacral ligaments are clamped, cut and ligated(Option C)</strong></li><li>Transverse cervical ligament are clamped cut and ligated</li><li>Vagina is opened at cervico vaginal junction. The vault of vagina is sutured.</li><li>Abdomen is closed in layers</li></ul><p><strong>Reference:</strong> D.C. dutta textbook of gynecology. Chapter 35, operative gynecology, page number:493</p>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Repeat Pap smear in 6 months</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Loop electrosurgical excision procedure (LEEP)</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Cold knife conization</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">HPV DNA testing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old woman with a history of treated cervical intraepithelial neoplasia (CIN) 3 presents for routine follow-up. She is asymptomatic. A Pap smear shows high-grade squamous intraepithelial lesion (HSIL). Colposcopy reveals a lesion involving the endocervical canal with unsatisfactory visualization. What is the next best step in management?</span></p>",
      "unique_key": "Q237679",
      "question_audio": null,
      "question_video": null,
      "map_id": 237679,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The patient has a history of high-grade lesions (CIN 3) and current Pap smear findings of HSIL with an unsatisfactory colposcopy, indicating possible involvement of the endocervical canal. <strong>Cold knife conisation (OPTION C)</strong> is indicated to obtain a clear margin diagnosis and to rule out invasive carcinoma when colposcopy is unsatisfactory or lesions extend into the canal. <strong>LEEP (OPTION B)</strong> can also be used but is generally reserved when colposcopy is satisfactory and visible. <strong>Repeat Pap smear (OPTION A)</strong> or <strong>HPV testing (OPTION D)</strong> alone is not appropriate given the high suspicion for high-grade disease.</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/4E.jpg\"><p><strong>Reference:</strong> Shaw's Gynaecology 17th edition, Chapter 33 Preinvasive &amp; Invasive Cancer of Cervix Page number. 418-419</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Breast: Agonist</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Bone: Antagonist</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Lipid: Antagonist</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrium: agonist</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55 year old woman with amenorrhea for one year is prescribed the drug Tamoxifen by her gynecologist.  What would be the correct effect of the drug on the tissues?</span></p>",
      "unique_key": "Q237680",
      "question_audio": null,
      "question_video": null,
      "map_id": 237680,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>Tamoxifen is an SERM, which works as a synthetic estradiol, as a type of selective steroid receptor modulator.</p><ul><li>The response is modified by the relative expression of ER-alpha and ER-beta receptors in the target tissue.</li><li>The hormonal milieu: affects the agonist-antagonist profile of a specific SERM.</li><li>An SERM may act as an estrogen agonist in a low-estrogen state -- menopause,</li><li>It may act as a competitive antagonist in a patient with high circulating estradiol levels.</li><li>Here the patient is likely menopausal, which is low estrogen state.</li><li>In this condition: Tamoxifen acts as an agonist on the endometrium.</li></ul><p>Incorrect answers:</p><p>Appropriate Action of the Tamoxifen on the given tissues would be:</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/5E.jpg\"><p><strong>Reference:</strong> William's Gynecology, chapter 16, page number:365-366, table: 16-7.</p>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial  hyperplasia with 50 % undifferentiated cells with referred pain  to iliac fossa.</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial hyperplasia \"Swiss cheese appearance\" in histology</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Saline infusion sonography: hypoechoic background with hyperechoic solid lesion arising from endometrium.</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Venetian blind appearance on TVS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A nulliparous 48 year old woman with presents pelvic pain and discomfort which she has been ignoring as dysmenorrhea. She had 7 weeks of amenorrhea followed by a large amount of bleeding, not associated with pain. Treatment with progestogen is indicated in:</span></p>",
      "unique_key": "Q237681",
      "question_audio": null,
      "question_video": null,
      "map_id": 237681,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<ul><li>Endometrial hyperplasia which shows Swiss cheese appearance in histology is a pathognomonic sign of metropathia hemorrhagica.</li><li>It is a specialised form of Dysfunctional Uterine Bleeding(DUB) -- usually seen in premenopausal women between the ages of 40 to 50.</li><li>There is intense cystic glandular hypertrophy</li><li>Some glands are small and summer large giving the appearance of a Swiss cheese glands empty with columnar epithelium</li><li>Presentation includes prolonged amenorrhea of 6 to 8 weeks followed by excessive bleeding which is painless -- anovulatory bleeding.</li><li>Its treatment of choice is progestogen.</li></ul><p>Incorrect answers</p><p>A: Endometrial hyperplasia waits around 50% undifferentiated cells is likely an endometrial tumour, presenting with common association of Simpson's pain [referred pain to iliac fossae or hypogastrium.</p><p>C: Saline infusion sonography is the test of choice for identifying polyps which are characterised by hypoechoic background showing hyperechoic solid polyp arising from the endometrium.</p><p>D: Venetian blind appearance on TVS is shown by adenomyosis, treatment of choice for this is surgery -- total hysterectomy or levonorgestrel containing IUCDs.</p><p><strong>Reference:</strong> William's gynecology, 4th edition, chapter 8, page number:187-93.</p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase of FSH leading to formation of the dominant follicle</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Proliferation of the endometrium</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Positive feedback of LH</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular atresia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Granulosa cell tumors lead to feminizing of the body due to X hormone; which of the following is not a normal sequelae of that hormone?</span></p>",
      "unique_key": "Q237682",
      "question_audio": null,
      "question_video": null,
      "map_id": 237682,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The granulosa cell tumors release estrogen; the effects of which are feminizing on the body and lead to hyperestrogenic status.</p><p>Incorrect answers:</p><p>Option B: Estrogen leads to proliferation of the endometrium in the first half of the menstrual cycle.</p><p>Option C: It leads to the positive feedback of LH occurring before ovulation.</p><p>Option D: It also leads to follicular atresia through positive feedback on LH and by its own action.</p><p><strong>Reference:</strong> williams gynecology, 4th edition, chapter 16, page number:346 to 349.</p>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Size of the tumor</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Histological grade</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Depth of invasion</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymph node involvement</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman presents with a large, rapidly growing vulvar mass. Biopsy reveals vulvar squamous cell carcinoma. What is the most important prognostic factor for this patient?<br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/8Q.jpg\"></span></p>",
      "unique_key": "Q237683",
      "question_audio": null,
      "question_video": null,
      "map_id": 237683,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The most important prognostic factor in vulvar squamous cell carcinoma is <strong>lymph node involvement (Option D).</strong> This factor significantly influences the overall survival and prognosis of the patient. The presence of metastatic spread to the inguinal or pelvic lymph nodes dramatically worsens the prognosis and is associated with a higher risk of recurrence and lower survival rates.</p><p><strong>OPTION A: Size of the Tumor:</strong> While tumor size is important, it is not as predictive of outcomes as lymph node status.</p><p><strong>OPTION B: Histological Grade:</strong> The histological grade can provide some prognostic information, but it is not as impactful as lymph node involvement.</p><p><strong>OPTION C: Depth of Invasion:</strong> The depth of invasion is also an important factor, particularly in early-stage disease, but again, it does not outweigh the impact of lymph node involvement.</p><p>Therefore, lymph node status is the most significant prognostic indicator in vulvar squamous cell carcinoma, guiding the treatment approach and informing the prognosis.</p><p><strong>Reference:</strong> Williams Gynaecology 3rd edition, Chapter 31 Vulvar Cancer Page number. 684</p>",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">19 years</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">20 years</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">21 years</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">22 years</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The ACOG recommends that women should initiate screening for cervical carcinoma irrespective of sexual activity ?</span></p>",
      "unique_key": "Q237684",
      "question_audio": null,
      "question_video": null,
      "map_id": 237684,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>According to ACOG, screening for Ca Cervix should start from 21 years age.</p><p>Following are the recommendations:</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/9E.jpg\"><p><strong>Reference:</strong> American college of obstetrics and gynecology. Updated cervical cancer screening guidelines. 2020</p>",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">IB3</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">IIA1</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">IIA2</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">IIIA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Invasive cervical carcinoma < 4 cm in greatest diameter and involving the upper two thirds of vagina without parametrial involvement is which stage ?</span></p>",
      "unique_key": "Q237685",
      "question_audio": null,
      "question_video": null,
      "map_id": 237685,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>Kindly refer to the table :</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/10E1.jpg\"><p><strong>Reference:</strong> Berek and Novak's, Gynecology, South Asia Edition, chapter 38. page number. 1062</p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">31</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">33</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">45</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">53</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The nonavalent HPV vaccine prevents all the strains of HPV except ?</span></p>",
      "unique_key": "Q237686",
      "question_audio": null,
      "question_video": null,
      "map_id": 237686,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>The nonavalent vaccine protects against &gt;99% of HPV diseases related to genotypes 6, 11, 16, 18, 31, 33, 45, 52, 58. This includes prevention against cervical, vaginal, vulvar and anal diseases</p><p>ACOG committee guidelines on HPV vaccination</p><ul><li>The Advisory Committee on Immunization Practices and ACOG recommend routine human papillomavirus (HPV) vaccination for girls and boys at the target age of 11-12 years (but it may be given from the age of 9 years) as part of the adolescent immunization platform.</li><li>Obstetrician-gynecologists should assess and vaccinate adolescent girls and young women with the HPV vaccine during the catch-up period (ages 13-26 years), regardless of sexual activity, prior exposure to HPV, or sexual orientation, if they were not vaccinated in the target age of 11-12 years</li><li>For some women aged 27-45 years who are previously unvaccinated, obstetrician-gynecologists and other health care professionals may use shared clinical decision making regarding the HPV vaccination, considering the patient's risk for acquisition of a new HPV infection and whether the HPV vaccine may provide benefit.</li><li>The American College of Obstetrician-Gynecologists does not recommend that an individual who received the quadrivalent HPV vaccine be revaccinated with 9-valent HPV vaccine, including those aged 27-45 years who previously completed some, but not all, of the vaccine series when they were younger.</li><li>Vaccination is recommended for women through age 26 years even if the patient is tested for HPV DNA and the results are positive.</li><li>Testing for HPV DNA is not recommended before vaccination.</li><li>Human papillomavirus vaccination is not recommended during pregnancy; however, routine pregnancy testing is not recommended before vaccination.</li><li>The HPV vaccine can and should be given to breastfeeding women age 26 years and younger who have not previously been vaccinated.</li><li>In children with a history of sexual abuse or assault, the HPV vaccine should be given as early as possible, starting at age 9 years</li></ul><p><strong>Reference:</strong> American College of Obstetrics and Gynecology. Human papillomavirus vaccination. ACOG committee opinion, page number 809</p>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Large cell keratinising type have a better prognosis than small cell type</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Cervical cancer is staged clinically</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">In 2018 FIGO staging system, horizontal spread is no longer considered in stage 1A</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenocarcinoma is more common in second decade</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following about cervical cancer is true except ?</span></p>",
      "unique_key": "Q237687",
      "question_audio": null,
      "question_video": null,
      "map_id": 237687,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>According to the 2018 staging system, the imaging and pathological findings are also included into the staging. It is no longer purely clinical</p><p>Adenocarcinoma cervix:</p><ul><li>More common in 20s and 30s</li><li>Adenocarcinoma in situ is the precursor to the carcinoma</li><li>Patient with AIS who are treated with conization need to be closely monitored</li><li>Patients with AIS with completed family history should undergo hysterectomy</li><li>Adenocarcinoma of cervix is managed in same manner as squamous cell carcinoma</li></ul><p>Histologic variants of cervical cancer :</p><ul><li>Large cell keratinising</li><li>Large cell non keratinising</li><li>Small cell &rarr; poorly differentiated. Worse prognosis</li></ul><p><strong>Reference:</strong> Berek and Novak's, Gynecology, South Asia Edition, chapter 38. page number. 1061</p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">CA 125</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">CEA</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">CA 72-A</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">CA 19-9</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a tumor marker used for diagnosis of mucinous ovarian malignancy ?</span></p>",
      "unique_key": "Q237688",
      "question_audio": null,
      "question_video": null,
      "map_id": 237688,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>Mucinous tumors :</p><ul><li>Cystic ovarian tumors</li><li>8 to 10 % of epithelial ovarian tumors</li><li>Pseudomyxoma peritonei : abundant mucoid material in abdominal cavity surrounded by fibrous tissue. Seen in appendiceal mucinous neoplasm, mucinous ovarian tumors</li><li>Mucinous tumors have raised CA 19-9, CA 125 and CEA levels</li></ul><p>Important tumor markers of ovarian tumors are as follows:</p><ul><li>Yolk sac tumor: AFP(main),LDH,alpha 1 AT</li><li>Dysgerminoma: LDH(main),PLAP,HCG</li><li>Teratoma: HCG,AFP,LDH</li><li>Choriocarcinoma: HCG</li><li>Embryonal cancer: AFP,HCG</li><li>Epithelial tumors: CEA,CA 19-9,CA 125, CA 72-A</li></ul><p><strong>Reference:</strong> Berek and Novak's, Gynecology, South Asia Edition, chapter 39, ovarian, fallopian tube and peritoneal cancer. page number:1105</p>",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Granulosa cell tumor</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Yolk sac tumor</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Embryonal carcinoma</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Leydig cell tumor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Reinke crystals are pathognomonic of which ovarian tumor?</span></p>",
      "unique_key": "Q237689",
      "question_audio": null,
      "question_video": null,
      "map_id": 237689,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p>Classification of ovarian tumors:</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/14E.jpg\"><p><strong>Option A: Granulosa cell tumor</strong></p><p>Granulosa cell tumors are sex cord-stromal tumors of the ovary and do not contain Reinke crystals. They are known for producing estrogen and are associated with <strong>Call-Exner bodies</strong> (small, follicle-like structures) and coffee bean-shaped nuclei but not Reinke crystals.</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/14E1.jpg\"><p>Fig: Histopathology of Granulosa cell tumor(inside black circles are the Call exner bodies)</p><p><strong>Option B: Yolk sac tumor</strong></p><p>Yolk sac tumors, also known as endodermal sinus tumors, are a type of germ cell tumor characterized by <strong>Schiller-Duval bodies</strong> and elevated alpha-fetoprotein (AFP) levels. They do not contain Reinke crystals, making them unrelated to this specific histological feature.</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/14E2.jpg\"><p>Fig: Histopathology of Yolk sac tumor</p><p><strong>Option C: Embryonal carcinoma</strong></p><p>Embryonal carcinoma is a rare and highly malignant germ cell tumor of the ovary. It typically shows <strong>undifferentiated cells that resemble early embryonic cells</strong> and may produce hCG, but it does not contain Reinke crystals.</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/14E3.jpg\"><p>Fig: Histopathology of embryonal cell carcinoma</p><p><strong>Option D: Leydig cell tumor</strong></p><p>Leydig cell tumors, a subset of sex cord-stromal tumors, are the only ovarian tumors associated with the presence of <strong>Reinke crystals.</strong> These tumors arise from ovarian stromal cells and may produce androgens, leading to virilization. Reinke crystals are <strong>eosinophilic, rod-like cytoplasmic inclusions</strong> that are pathognomonic of Leydig cell tumors, aiding in their diagnosis.</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/14E4.jpg\"><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/14E5.jpg\"><p>Fig: Histopathology of Leydig cell tumor</p><p><strong>Reference:</strong> Shaw's Gynaecology 17th edition, Page number. 449</p>",
      "correct_choice_id": 134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilateral salpingo-oophorectomy</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Unilateral salpingo-oophorectomy</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Chemotherapy alone</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Total abdominal hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the treatment of choice for a stage IA dysgerminoma in a young woman desiring fertility preservation?</span></p>",
      "unique_key": "Q237690",
      "question_audio": null,
      "question_video": null,
      "map_id": 237690,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>OPTION B. Unilateral salpingo-oophorectomy:</strong></p><p>Unilateral salpingo-oophorectomy involves the removal of the affected ovary and fallopian tube while preserving the contralateral ovary and the uterus. <strong>This approach is the treatment of choice for stage IA dysgerminoma in patients desiring fertility preservation because it effectively removes the tumor while maintaining reproductive potential.</strong> Dysgerminomas are typically unilateral, and the prognosis for stage IA is excellent, making this the correct answer.</p><p><strong>Option A. Bilateral salpingo-oophorectomy:</strong></p><p>Bilateral salpingo-oophorectomy involves the removal of both ovaries and fallopian tubes. While this approach ensures complete removal of the tumor and eliminates the risk of recurrence, it also results in the loss of fertility, as both ovaries are removed. <strong>This option is not suitable for a young woman who desires fertility preservation,</strong> making it incorrect in this scenario.</p><p><strong>OPTION C. Chemotherapy alone:</strong></p><p>Chemotherapy is generally used in cases where there is a higher stage of disease, recurrence, or when there is evidence of residual disease post-surgery. For stage IA dysgerminoma, surgery alone (unilateral salpingo-oophorectomy) is usually curative, and chemotherapy is not required unless there are additional risk factors or spread beyond the ovary. Thus, chemotherapy alone is not the first-line treatment for stage IA dysgerminoma.</p><p><strong>OPTION D. Total abdominal hysterectomy:</strong></p><p>Total abdominal hysterectomy involves the removal of the uterus and is not necessary for the treatment of stage IA dysgerminoma. It would not be appropriate for a young woman seeking fertility preservation, as it would eliminate her ability to carry a pregnancy. Therefore, this option is overly aggressive and unnecessary for early-stage dysgerminoma, making it an incorrect choice.</p><p>Key takeaway: FIGO Staging of Ovarian carcinoma:</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/OBGMiniVII24112024/15E.jpg\"><p>Stagewise management:</p><p>Stage I,II: Surgery:</p><ul><li><strong>TAH-BSO</strong> and <strong>omentectomy.</strong></li><li><strong>Peritoneal washings</strong> for cytology.</li><li><strong>Debulking surgery</strong> to remove as much tumor as possible.</li></ul><p><strong>Adjuvant Chemotherapy:</strong></p><ul><li>Carboplatin and Paclitaxel for 6 cycles.</li></ul><p>Stage III,IV: Surgery:</p><ul><li><strong>Debulking surgery:</strong> Removal of as much tumor as possible, including peritoneal implants.</li><li><strong>TAH-BSO</strong> and <strong>omentectomy.</strong></li><li><strong>Lymphadenectomy:</strong> Removal of affected lymph nodes.</li></ul><p><strong>Adjuvant Chemotherapy:</strong></p><ul><li><strong>Carboplatin</strong> and <strong>Paclitaxel</strong> for 6 cycles.</li></ul><p>Consideration of <strong>intraperitoneal chemotherapy</strong> in some cases.</p><ul><li><strong>Palliative Care:</strong></li></ul><p>Focus on symptom management, including pain control and support for quality of life.</p><p><strong>Reference:</strong> Williams Gynaecology 3rd edition, Page number. 763</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}